MLAB
NASDAQ · Life Sciences Tools & Services
Mesa Laboratories Inc
$96.47
-4.03 (-4.01%)
Financial Highlights (FY 2026)
Revenue
247.48M
Net Income
-2,027,014
Gross Margin
63.1%
Profit Margin
-0.8%
Rev Growth
+9.4%
D/E Ratio
1.11
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 63.1% | 63.1% | 47.0% | 47.0% |
| Operating Margin | 8.0% | 7.2% | 10.0% | 10.8% |
| Profit Margin | -0.8% | -0.8% | 7.4% | 9.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 247.48M | 226.32M | 397.89M | 376.18M |
| Gross Profit | 156.21M | 142.85M | 187.01M | 176.81M |
| Operating Income | 19.75M | 16.25M | 39.90M | 40.62M |
| Net Income | -2,027,014 | -1,668,324 | 29.46M | 36.94M |
| Gross Margin | 63.1% | 63.1% | 47.0% | 47.0% |
| Operating Margin | 8.0% | 7.2% | 10.0% | 10.8% |
| Profit Margin | -0.8% | -0.8% | 7.4% | 9.8% |
| Rev Growth | +9.4% | +9.4% | +8.2% | -1.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 141.47M | 141.47M | 71.22M | 83.37M |
| Total Equity | 127.06M | 127.06M | 387.20M | 405.59M |
| D/E Ratio | 1.11 | 1.11 | 0.18 | 0.21 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 35.25M | 30.62M | 61.24M | 58.33M |
| Free Cash Flow | — | — | 38.36M | 33.12M |